Xinzhou Li - Net Worth and Insider Trading
Xinzhou Li Net Worth
The estimated net worth of Xinzhou Li is at least $0 dollars as of 2024-07-17. Xinzhou Li is the 10% Owner of NovaBay Pharmaceuticals Inc and owns about 0 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $0. Details can be seen in Xinzhou Li's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Xinzhou Li has not made any transactions after 2013-09-20 and currently still holds the listed stock(s).
Transaction Summary of Xinzhou Li
Xinzhou Li Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Xinzhou Li owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .
Click here to see the complete history of Xinzhou Li’s form 4 insider trades.
Insider Ownership Summary of Xinzhou Li
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBY | NovaBay Pharmaceuticals Inc | 2013-09-20 | 10 percent owner |
Xinzhou Li Latest Holdings Summary
Xinzhou Li currently owns a total of 1 stock. Xinzhou Li owns 0 shares of NovaBay Pharmaceuticals Inc (NBY) as of September 20, 2013, with a value of $0.
Latest Holdings of Xinzhou Li
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals Inc | 2013-09-20 | 0 | 2.14 | 0 |
Holding Weightings of Xinzhou Li
Xinzhou Li Form 4 Trading Tracker
According to the SEC Form 4 filings, Xinzhou Li has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the sale of 4 shares on September 20, 2013, which brought Xinzhou Li around $224,400.
Insider Trading History of Xinzhou Li
- 1
Xinzhou Li Trading Performance
GuruFocus tracks the stock performance after each of Xinzhou Li's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Xinzhou Li is -5.83%. GuruFocus also compares Xinzhou Li's trading performance to market benchmark return within the same time period. The performance of stocks bought by Xinzhou Li within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Xinzhou Li's insider trading performs compared to the benchmark.
Performance of Xinzhou Li
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.28 | | | | | |
| Relative Return to S&P 500(%) | -0.69 | | | | | |
Xinzhou Li Ownership Network
Xinzhou Li Owned Company Details
What does NovaBay Pharmaceuticals Inc do?
Who are the key executives at NovaBay Pharmaceuticals Inc?
Xinzhou Li is the 10 percent owner of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .
NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovaBay Pharmaceuticals Inc Insider Transactions
Xinzhou Li Mailing Address
Above is the net worth, insider trading, and ownership report for Xinzhou Li. You might contact Xinzhou Li via mailing address: Wangquiao, No. 1000, Pudong New Area, Shanghai F4 F4.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
